Skip to main content
BIOX
NASDAQ Industrial Applications And Services

Bioceres Reports $10M Net Loss, Negative EBITDA Amid Revenue Decline and Ongoing Debt Issues

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$0.451
Mkt Cap
$28.516M
52W Low
$0.347
52W High
$5.175
Market data snapshot near publication time

summarizeSummary

Bioceres Crop Solutions reported a significant fiscal third-quarter net loss of $10.0 million and negative Adjusted EBITDA, driven by a 23% revenue decline and ongoing challenges following the Pro Farm Group foreclosure.


check_boxKey Events

  • Significant Financial Deterioration

    The company reported a net loss of $10.0 million and negative Adjusted EBITDA of $(0.6) million for the fiscal third quarter, a sharp decline from prior year profits.

  • Revenue Decline

    Total revenues fell 23% year-over-year to $39.4 million, impacted by softer demand in Crop Protection and an ongoing transition in the Seeds segment.

  • Gross Margin Contraction

    Gross profit decreased 30% to $12.7 million, with gross margin falling to 32% due to lower revenues, product mix effects, and inventory obsolescence adjustments.

  • Ongoing Liability Management

    Bioceres continues debt reprofiling efforts and a voluntary bond maturity extension process in Argentina, with $108.3 million in secured notes still classified as short-term debt due to a disputed foreclosure.


auto_awesomeAnalysis

The substantial net loss of $10.0 million and negative Adjusted EBITDA of $(0.6) million, coupled with a significant 23% revenue decline, confirm a deepening of the company's severe financial distress. These results exacerbate concerns for a company already operating under a going concern warning and facing a Nasdaq delisting threat. The ongoing liability management efforts and the unresolved legal dispute surrounding the Pro Farm Group foreclosure add significant uncertainty to the company's operational and financial future.

At the time of this filing, BIOX was trading at $0.45 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $28.5M. The 52-week trading range was $0.35 to $5.18. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed BIOX - Latest Insights

BIOX
May 12, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
9
BIOX
May 11, 2026, 5:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
BIOX
Apr 28, 2026, 11:23 AM EDT
Source: Reuters
Importance Score:
8
BIOX
Apr 28, 2026, 11:11 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
BIOX
Mar 24, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
BIOX
Mar 17, 2026, 9:16 AM EDT
Filing Type: 6-K
Importance Score:
9
BIOX
Mar 13, 2026, 5:23 PM EDT
Filing Type: 6-K
Importance Score:
10
BIOX
Mar 13, 2026, 4:15 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
BIOX
Mar 05, 2026, 4:10 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
BIOX
Feb 05, 2026, 5:49 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7